US Stock MarketDetailed Quotes
RVVTF REVIVE THERAPEUTICS LTD
- 0.020550
- -0.000950-4.42%
15min DelayClose Apr 25 16:00 ET
7.37MMarket Cap-2283P/E (TTM)
0.022050High0.018500Low240.12KVolume0.020300Open0.021500Pre Close4.76KTurnover0.07%Turnover RatioLossP/E (Static)358.45MShares0.06400052wk High1.08P/B7.37MFloat Cap0.01600052wk Low--Dividend TTM358.45MShs Float0.510000Historical High--Div YieldTTM16.51%Amplitude0.016000Historical Low0.019000Avg Price1Lot Size
REVIVE THERAPEUTICS LTD Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | (Q2)Dec 31, 2021 | (Q1)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -48.86%783.56K | -75.30%413.53K | -69.04%5.52M | -62.77%1.53M | -65.77%1.67M | -4.08%17.83M | -60.86%2.8M | 41.32%6.03M | 55.69%4.12M | 7.89%4.89M |
| Selling and administrative expenses | 3.83%278.83K | -40.45%252.66K | -28.84%1.77M | -77.69%268.55K | -32.67%424.25K | -78.42%2.49M | -92.12%366.19K | -71.84%292.31K | -24.71%1.2M | -85.23%630.1K |
| -Selling and marketing expense | ---- | ---- | 3,717.89%313.64K | ---- | ---- | -97.01%8.22K | --1.56K | --6.66K | ---- | ---- |
| -General and administrative expense | 3.83%278.83K | -40.45%252.66K | -41.23%1.46M | -77.69%268.55K | -32.67%424.25K | -77.96%2.48M | -92.15%364.63K | -72.49%285.65K | -24.45%1.2M | -84.23%630.1K |
| Research and development costs | -65.16%433.22K | -88.49%133.39K | -76.36%3.58M | -56.52%1.24M | -72.56%1.16M | 126.05%15.16M | -4.35%2.36M | 92.67%5.71M | 177.59%2.86M | 1,656.85%4.22M |
| Depreciation amortization depletion | -24.77%82 | -24.07%82 | -24.91%434 | -24.83%109 | -25.00%108 | -25.42%578 | -25.26%145 | -25.39%144 | -25.26%145 | -25.77%144 |
| -Depreciation and amortization | -24.77%82 | -24.07%82 | -24.91%434 | -24.83%109 | -25.00%108 | -25.42%578 | -25.26%145 | -25.39%144 | -25.26%145 | -25.77%144 |
| Other operating expenses | 251.63%71.42K | -69.73%27.4K | -11.06%163.98K | -60.87%20.31K | 152.87%90.51K | -45.75%184.37K | 108.01%67.87K | -89.15%28.79K | 264.63%51.91K | 29.55%35.79K |
| Operating profit | 48.86%-783.56K | 75.30%-413.53K | 69.04%-5.52M | 62.77%-1.53M | 65.77%-1.67M | 4.08%-17.83M | 60.86%-2.8M | -41.32%-6.03M | -55.69%-4.12M | -7.89%-4.89M |
| Net non-operating interest income expense | 77.20%12.93K | 54.53%22.9K | 22.37%64.61K | -57.53%7.3K | -25.56%14.82K | 197.43%52.8K | -60.76%9.42K | 417.53%6.28K | 908.37%17.19K | 1,027.39%19.91K |
| Non-operating interest income | -2.51%19.61K | 7.04%31.38K | -8.43%112.79K | -43.66%20.12K | -25.34%29.32K | 19.48%123.16K | -43.16%24.88K | 23.65%23.31K | 80.02%35.71K | 90.45%39.27K |
| Non-operating interest expense | -49.54%5.9K | -42.34%7.48K | -30.63%44K | -28.80%11.7K | -25.72%12.97K | -19.70%63.42K | -23.00%14.19K | -20.67%15.34K | -18.64%16.43K | -16.93%17.47K |
| Total other finance cost | -30.68%775 | -34.56%996 | -39.84%4.18K | -46.40%1.12K | -19.60%1.52K | 9.38%6.94K | -5.35%1.28K | 12.78%1.69K | 18.46%2.09K | 8.67%1.89K |
| Other net income (expense) | -3,137.71%-864.5K | 98.27%-26.7K | ||||||||
| Gain on sale of security | ---- | ---- | ---87.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | ---- | ---- | -2,810.00%-777K | ---- | ---- | 98.45%-26.7K | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | --777K | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -98.45%26.7K | ---- | ---- | ---- | ---- |
| Income before tax | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M | -41.11%-6.02M | -65.48%-4.1M | -7.69%-4.87M |
| Income tax | ||||||||||
| Net income | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M | -41.11%-6.02M | -65.48%-4.1M | -7.69%-4.87M |
| Net income continuous Operations | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M | -41.11%-6.02M | -65.48%-4.1M | -7.69%-4.87M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M | -41.11%-6.02M | -65.48%-4.1M | -7.69%-4.87M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M | -41.11%-6.02M | -65.48%-4.1M | -7.69%-4.87M |
| Basic earnings per share | 54.11%-0.0022 | 89.08%-0.0011 | 66.67%-0.02 | 53.06%-0.0047 | 50.00%-0.01 | 25.00%-0.06 | 66.67%-0.01 | -100.00%-0.02 | 0.00%-0.01 | 0.00%-0.02 |
| Diluted earnings per share | 54.11%-0.0022 | 89.08%-0.0011 | 66.67%-0.02 | 53.06%-0.0047 | 50.00%-0.01 | 25.00%-0.06 | 66.67%-0.01 | -100.00%-0.02 | 0.00%-0.01 | 0.00%-0.02 |
| Dividend per share | ||||||||||
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg